Genprex, Inc.
Clinical trials sponsored by Genprex, Inc., explained in plain language.
-
First-of-its-Kind gene therapy trial offers new hope for lung cancer patients
Disease control Recruiting nowThis study is testing a new gene therapy drug called Reqorsa, given alongside an existing lung cancer drug (osimertinib), for patients whose advanced lung cancer has started growing again while on osimertinib. The goal is to see if this combination is safe and can help control th…
Phase: PHASE1, PHASE2 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New gene therapy combo aims to keep aggressive lung cancer at bay
Disease control Recruiting nowThis study is testing a new combination treatment for people with an advanced form of small cell lung cancer. After initial chemotherapy, patients who are stable will receive a new gene therapy drug (quaratusugene ozeplasmid) along with an existing immunotherapy (atezolizumab) to…
Phase: PHASE1, PHASE2 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC